Invivyd (IVVD) Receivables - Other (2022 - 2025)

Invivyd (IVVD) reported Receivables - Other of $676000.0 for Q4 2025, up 157.03% on a YoY basis from $263000.0 in Q4 2024, and up 139.72% quarter-over-quarter from $282000.0 in Q3 2025.

Invivyd (IVVD) Receivables - Other (2022 - 2025) Analysis & Trends

Invivyd has reported Receivables - Other for 4 years, with the latest figure at $676000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other rose 157.03% year-over-year to $676000.0; the trailing twelve-month figure through Dec 2025 stood at $676000.0 (up 157.03% YoY), and the FY2025 full-year result was $676000.0, up 157.03% from the prior year.
  • Receivables - Other for Q4 2025 stood at $676000.0, up from $282000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $933000.0 in Q4 2023, with the low at $111000.0 in Q2 2025.
  • Historically, Receivables - Other has averaged $504500.0 across 4 years, with a median of $496500.0 in 2023.
  • The largest YoY upside for Receivables - Other was 157.03% in 2025 against a maximum downside of 82.63% in 2025.
  • Invivyd's Receivables - Other stood at $377000.0 in 2022, then soared by 147.48% to $933000.0 in 2023, then tumbled by 71.81% to $263000.0 in 2024, then jumped by 157.03% to $676000.0 in 2025.
  • The last three Receivables - Other figures came in at $676000.0 (Q4 2025), $282000.0 (Q3 2025), and $111000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Invivyd 168.41 Mn -58.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 676,000.00
Dec 31, 2025 676,000.00
Sep 30, 2025 282,000.00
Sep 30, 2025 282,000.00
Jun 30, 2025 111,000.00
Jun 30, 2025 111,000.00
Mar 31, 2025 192,000.00
Mar 31, 2025 192,000.00
Dec 31, 2024 263,000.00
Dec 31, 2024 263,000.00
Sep 30, 2024 460,000.00
Sep 30, 2024 460,000.00
Jun 30, 2024 639,000.00
Jun 30, 2024 639,000.00
Mar 31, 2024 875,000.00
Mar 31, 2024 875,000.00
Dec 31, 2023 933,000.00
Dec 31, 2023 933,000.00
Sep 30, 2023 713,000.00
Sep 30, 2023 713,000.00